Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 17

Metabolic Syndrome and Socioeconomic Status in Association with Chronic Kidney Disease: A Cross-Sectional Study in Ningbo, China

Authors Huang S, Yao X, Chen X, Chen X, Li Y, Kanwar Y, Chan FKS, Ye P, Zhan M

Received 11 April 2024

Accepted for publication 15 October 2024

Published 21 October 2024 Volume 2024:17 Pages 3891—3901

DOI https://doi.org/10.2147/DMSO.S473299

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Konstantinos Tziomalos



Shichun Huang,1,2 Xuejie Yao,2 Xueqin Chen,2 Xiuli Chen,3 Yanxia Li,3 Yashpal Kanwar,4 Faith Ka Shun Chan,5 Ping Ye,2 Ming Zhan2,6

1School of Medicine, Ningbo University, Ningbo, 315211, People’s Republic of China; 2Department of Medicine, The First Affiliated Hospital, Ningbo University, Ningbo, 315000, People’s Republic of China; 3Department of Medicine, Ningbo Baiyun Community Healthcare Center, Ningbo, 315000, People’s Republic of China; 4Department of Pathology and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA; 5School of Geographical Sciences, University of Nottingham Ningbo China, Ningbo, 315100, People’s Republic of China; 6China Health Institute, University of Nottingham Ningbo China, Ningbo, 315100, People’s Republic of China

Correspondence: Ming Zhan, Department of Medicine, The First Affiliated Hospital, Ningbo University, 59 Liuting Street, Ningbo, Zhejiang Province, 315000, People’s Republic of China, Email [email protected]

Background: Metabolic syndrome (MS) and low socioeconomic status (SES) may increase the risk for chronic kidney disease (CKD). This study aimed to investigate the prevalence of MS and CKD and the association between MS, SES, and CKD among adults in Ningbo, a city in Eastern China.
Methods: A cross-sectional survey of 3212 adults was conducted between July 2019 and February 2021 in Ningbo. MS was defined as the presence of three or more risk factors: elevated blood pressure, reduced high-density lipoprotein (HDL) cholesterol, elevated triglycerides, elevated plasma glucose, and abdominal obesity. CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 or the occurrence of albuminuria. SES was stratified according to personal education and income levels. Multivariate logistic regression was used to analyze the relationships among MS, sociodemographic factors, and CKD.
Results: The age- and sex-adjusted prevalence of CKD was 9.1% (95% CI: 8.3– 10.0), the prevalence of eGFR less than 60 mL/min/per 1· 73 m² was 2.5% (95% CI 2.0– 3.0) and that of albuminuria was 7.9% (95% CI 7.0– 8.7), and the adjusted prevalence of MS was 23.1% (95% CI 21.7– 24.4). MS components, including elevated blood pressure, elevated fasting glucose, abdominal obesity, elevated serum triglyceride, or reduced serum HDL-C, were independent risk factors for CKD, and the adjusted prevalence of CKD proportionally increased with the number of MS-defined parameters. Participants with MS had 2.43-fold increased odds of developing CKD compared with those without MS. In addition, age, female sex, low SES including low educational level and low income were associated with increased odds of occurrence of albuminuria and CKD.
Conclusion: The prevalence of metabolic syndrome and chronic kidney disease is high among adults in Ningbo. Metabolic syndrome and low socioeconomic status are associated with the high risk of developing chronic kidney disease.

Keywords: chronic kidney disease, metabolic syndrome, socioeconomic status, prevalence, risk factors

Introduction

Chronic kidney disease (CKD) and metabolic syndrome (MS) are major health problems worldwide. CKD is recognized as a devastating medical, social, and economic problem in both developed and developing countries.1–3 It has been reported that more than 700 million people worldwide have chronic kidney disease.3 MS comprises a cluster of risk factors, including abdominal obesity, dyslipidemia, hypertension, and hyperglycemia,4 and is present in approximately 23.7% of adults.5 With rapid economic growth and sociodemographic transformation, the prevalence of MS and CKD is increasing in both developed and developing countries. CKD is considered a significant risk factor for cardiovascular disease and is independent of other conventional risk factors that are associated with an increased risk of mortality.6 Especially in patients with diabetes and hypertension, CKD is a risk multiplier and is associated with increased cardiovascular mortality.7,8

In recent years, cross-sectional studies have identified an independent association between MS and CKD. Furthermore, geographical region and economic status have been identified as risk factors independently associated with CKD in China.9 In economically developed urban regions of China, such as Beijing and Shanghai, the reported prevalence of CKD was 13.0%10 and 11.8%,11 respectively, similar to that reported in developed countries. China’s economy has developed rapidly in recent years, especially in the eastern coastal regions; however, epidemiological data on metabolic syndrome and CKD are scarce, and much less attention has been paid to their relevance. Ningbo is an eastern coastal city in China with rapid socioeconomic development, a population of 9.6 million and a total geographical size of 9816 km2.12 During the past three years, with an average annual increase of 7%, disposable income per capita in Ningbo was $9348 in 2022, much higher than the national average of $5269.12,13 These characteristics may make Ningbo as a prototype of fast-growing mid-sized cities in developing countries, however, the epidemiological information on MS and CKD in this city has been lacking during recent years. Thus, the present study aimed to investigate the prevalence of MS and CKD, the association between MS and CKD, and the association between socioeconomic factors and CKD in the adult population of Ningbo, Eastern China.

Methods

Study Participants

This study was a cross-sectional investigation of the association between MS and CKD in a representative sample of the general adult population in Ningbo City from July 2019 to February 2021. Ningbo City comprises ten districts, including eight urban districts and two rural counties. To ensure adequate representation, residents who lived for at least three years and were aged 20–79 years were selected using a multistage, stratified sampling method. First, three out of eight urban districts and one out of two rural districts were randomly selected in Ningbo: Cixi, Jiangbei, Haishu, and Ninghai districts, as shown in Figure 1. Five communities were randomly selected from each of the four districts, and 20 communities were chosen as the population base for the study. Finally, we randomly selected 150–200 adult individuals (random numbers generated by the SPSS software) from each selected community as representative samples. A total of 3720 individuals were included in the survey and physical examination. Of these, 3212 completed the entire questionnaire and underwent checkups. This study was approved by the Ethics Committee of the First Affiliated Hospital of Ningbo University (approval no: 2021RS010). Written informed consent was obtained from all participants before the commencement of the study.

Figure 1 The geography of Ningbo and the four randomly selected districts in the study. Ningbo is an eastern coastal city in China, with a population of 9.6 million. The city comprises ten subsections, including six urban districts: Haishu District, Jiangbei District, Zhenhai District, Beilun District, Yinzhou District, and Fenghua District; two satellite urban county-level cities: Cixi City and Yuyao City; and two rural counties: Ninghai County and Xiangshan County. A-D represent four randomly selected districts in this study.

Screening Protocol and Assessment Criteria

All participants attended the designated health checkup center and completed a comprehensive screening procedure, including a series of standardized questionnaires, physical examinations, and laboratory tests. Postgraduate medical students and physicians conducted the entire screening process and a systemic training course was offered to guarantee the quality of the study. Specifically, the questionnaire collected information regarding the participants’ socio-demographics, education levels, economic status, and medical history. The physical examination included height, weight, blood pressure, and waist circumference. For laboratory tests, a venous blood sample was collected after an overnight fast of at least 10 hours to measure fasting blood glucose, serum creatinine, serum lipid, and uric acid levels. Meanwhile, a clean-catch, midstream, morning urine specimen was collected for the evaluation of urinalysis and urine albumin to creatinine ratio (UACR). All blood and urine samples were tested in three central clinical laboratories of The First Affiliated Hospital of Ningbo University with the same standardization and quality control checks. Serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TGs), blood glucose, serum creatinine (SCr), and uric acid levels were measured using a Beckman Coulter AU5800 chemistry analyzer.

Chronic Kidney Disease

Chronic kidney disease was defined by the presence of reduced renal function as estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 and/or the occurrence of albuminuria. eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI).14 Urinary creatinine was measured using Jaffe’s kinetic method and urinary albumin was measured using the immuno-turbidimetric method on a morning spot urine sample. Albuminuria was defined as an UACR value higher than 30 mg/g.

Metabolic Syndrome

The metabolic syndrome was defined by the presence of three or more of the following five risk factors, according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) guidelines:4,15 (1) waist circumference measurement > 80 cm for women or > 90 cm for men (for Asian population), (2) serum triglycerides level ≥1.70 mmol/L (≥150 mg/dL), (3) serum high-density lipoprotein (HDL) cholesterol < 1.30 mmol/L (< 50 mg/dL) for women or < 1.04 mmol/L (< 40 mg/dL) for men, (4) blood pressure ≥130/85 mmHg and/or use of anti-hypertensive medications, and (5) fasting blood glucose ≥5.6 mmol/L (≥100 mg/dL) and/or use of insulin or hypoglycemic medication. Based on the presented number of risk factor components of MS, the study population was divided into 5 groups: participants with 0, 1, 2, 3, 4 or 5 MS components, respectively. Participants presented with ≥3 MS components are defined as having metabolic syndrome.

Hypertension and Diabetes Status

Hypertension was defined as meeting one of the following three criteria: average systolic blood pressure ≥140 mmHg or average diastolic blood pressure ≥90 mmHg, a history of hypertension, or receiving any current antihypertensive medication during the last two weeks. The procedure for measuring blood pressure was based on the Joint National Committee VIII criteria (JNC VIII).16 Diabetes was defined as a fasting plasma glucose ≥7.0 mmol/L (126 mg/dL) and/or a 2-hour postprandial plasma glucose ≥11.1 mmol/L (200 mg/dL), or a previously established diagnosis of diabetes, or current use of hypoglycemic agents, irrespective of glucose levels.

Socioeconomic Status

The socioeconomic status was evaluated via two-dimensional parameters, including self-reported education levels and personal annual income.17,18 Education levels were classified into three levels: low level was defined as receiving primary school education and below; medium level as having junior and high school education; high level as graduation from college and above. According to the Ningbo local statistics of personal income levels,12 annual individual income was also categorized as: low, Income≤ $5000/yr; medium, Income<$10,000/yr, >$5000/yr; high, Income≥ $10,000/yr. The SES was stratified into three groups accordingly: High SES belonged to those who had both high educational level and high annual income, low SES belonged to low educational level and low annual income, and the others were medium SES.

Statistical Analysis

Continuous variables are presented as mean ± SD. Quantitative variables are summarized as means and 95% confidence intervals (CI). Means were compared using the Student’s t-tests, and qualitative variables were compared using Pearson’s χ2 test. Bonferroni correction was further applied where multiple comparisons were made. Multivariate logistic regression analyses were used to estimate the odds ratios (OR) and CIs by comparing the risk factors associated with CKD. Univariate logistic regression analysis (unadjusted) and multivariate logistic regression analysis (adjusted for age and sex) were used to analyze the risk factors for CKD, the correlation between MS and its sub-items, and CKD, and the correlation between sociodemographic factors and CKD. The prevalence rate was adjusted according to the age and sex composition ratio of the 2020 seventh national population census in the Ningbo area.12 P-values<0.05 were considered to be statistically significant. All analyses were conducted using SPSS software (version 26.0; SPSS, Inc., Chicago, IL, USA).

Results

Characteristics of Study Participants

Of the 3720 subjects enrolled in the study, 3212 completed the study and were included in the final analysis, with an effective response rate of 86.3%. The general characteristics of the participants are presented by CKD status in Table 1. Among all the participants, 48.7% were male, and the mean age was 45.58 ±14.3 years. Compared with people without CKD, those with CKD were older, had a lower percentage of high school degrees, were more likely to be female, and had lower income levels. The blood pressure, fasting blood glucose level, waist circumference, triglyceride level, and other metabolic indices of patients with CKD were significantly higher than those of patients without CKD.

Table 1 Adjusted Characteristics of Participants with and without Chronic Kidney Disease

Prevalence of CKD and MS

The age- and sex-adjusted CKD prevalence in the study population was 9.1% (95% CI 8.3–10.0). The adjusted prevalence of eGFR less than 60 mL/min/per 1·73 m² was 2.5% (95% CI 2.0–3.0) and that of albuminuria was 7.9% (95% CI 7.0–8.7). The age- and sex-adjusted prevalence of MS was 23.1% (95% CI 21.7–24.4). As shown in Table 2, a general trend was observed in the study population that CKD prevalence increased with age, and there was a statistical difference in CKD prevalence across various age groups after Bonferroni correction (P<0.001).

Table 2 Prevalence of Albuminuria, Decreased eGFR and CKD in the Study Population by Different Age Groups

Association of CKD with MS

The age- and sex-adjusted prevalence of CKD among participants with and without one of these MS components is shown in Figure 2. The prevalence of CKD in people with elevated blood pressure, elevated fasting glucose, abdominal obesity, elevated serum triglyceride, or reduced serum HDL-C was higher than that in people without medical conditions, and the difference between the two groups was statistically significant (P<0.01). The age- and sex-adjusted prevalence of CKD increased significantly with an increase in the number of MS components (P<0.001, Figure 3). Furthermore, there was a significant dose-response relationship between the number of MS components and CKD prevalence (Table 3). Multivariate logistic regression analysis showed that participants with 1, 2, 3, 4 or 5 components of MS had 1.02-, 1.61-, 2.38-, and 3.86-fold increased odds of developing CKD compared with those without any component of MS (Table 3). Overall, people with MS had 2.43-fold increased odds of developing CKD compared with those without MS (OR=2.43, 95% CI: 1.81–3.27, P<0.001).

Table 3 Adjusted Odds Ratios of Chronic Kidney Disease Associated with Individual or Multiple Components of the Metabolic Syndrome

Figure 2 The adjusted prevalence of CKD in subjects with or without components of the metabolic syndrome. Data were age- and sex-adjusted prevalence (%). Yes = Subjects with the medical condition. No = Subjects without the medical condition. Elevated BP: blood pressure ≥ 130/85 mmHg; Elevated FBG: fasting blood glucose ≥5.6 mmol/L (≥100 mg/dL); Abdominal obesity: waist circumference ≥90 cm in men and ≥80 cm in women; Elevated TGs: serum triglyceride level ≥ 1.7 mmol/L (≥150 mg/dL); Reduced HDL-C: serum HDL cholesterol < 50 mg/dL (1.30 mmol/L) for women or < 40 mg/dL (1.04 mmol/L) for men. * p<0.01 compared with the subjects with the MS component.

Figure 3 The adjusted prevalence of CKD by the presented number of metabolic syndrome components. Data were age- and sex-adjusted prevalence (%). The five metabolic syndrome components include elevated blood pressure, reduced high-density lipoprotein cholesterol, elevated triglycerides, elevated plasma glucose, and abdominal obesity.

Association of CKD and MS with Sociodemographic Factors

Education and income levels are two major parameters of SES, and SES were stratified into three groups accordingly. Among the participants, the proportion of high, medium, and low SES was 23.3%, 50.3%, and 26.4%. As shown in Table 4, the prevalence of CKD was higher in the participants with low education level than that with medium and high education levels, and there was a statistical difference across those three education groups after Bonferroni correction (p<0.001), whereas the difference between low and medium education groups was not significant (p=0.083). Similarly, CKD prevalence was higher in the low-income group than that in medium and high income. The Bonferroni-corrected test revealed that the difference in CKD prevalence among those three income groups was statistically significant (p<0.001), but no statistical difference between groups of high and medium income (p=0.773). In addition, participants with low SES had a higher prevalence of albuminuria, and reduced eGFR and CKD, as compared to those with medium or high SES. After the Bonferroni-correction, there were statistical differences among those three SES groups regarding the prevalence of albuminuria, reduced eGFR and CKD, respectively (p<0.001), however, there was no statistical difference in the prevalence of reduced eGFR between low and medium SES groups (p=0.259).

Table 4 Prevalence of Albuminuria, Decreased eGFR and CKD in the Study Population by Different Education Level, Income and SES Groups

The association between the sociodemographic factors and CKD and MS was further analyzed. As shown in Table 5, multivariate logistic regression analysis revealed that age (by decade), female sex, low education level, low income and low SES were associated with increased odds of developing albuminuria and CKD (P<0.001), indicating that age, female sex and low SES were independent risk factors for the development of chronic kidney disease. In addition, except for female sex, age and low SES were also associated with increased odds of developing MS (P<0.001).

Table 5 Adjusted Odds Ratios of Albuminuria, Chronic Kidney Disease and Metabolic Syndrome Associated with Sociodemographic Factors

Discussion

In this study, we investigated the prevalence of CKD and its relationship with MS and SES. The study indicated that 9.1% of adults in this population had CKD, there was a significant positive association between metabolic syndrome and CKD, and an inverse relationship between SES and CKD. CKD risk increases with an increase in the number of MS components. These relationships were independent of age, sex, and other potential risk factors for CKD. Although several related studies have been conducted in major affluent Chinese cities, Ningbo is one of the typical mid-sized cities in China with rapid socioeconomic development. Moreover, it is representative of this category because its economic standing, education level, and health insurance coverage are higher than the national average, making our findings noteworthy of documentation. Given the fact that there is an increasing incidence of CKD worldwide, the identification of modifiable risk factors and their amelioration would improve the adverse outcome of the disease.

In 2017, the prevalence of CKD in the world’s population was estimated to be 9.1%, with one-third of the population living in China and India,19 which was similar to the prevalence in this study (9.1%). The prevalence of decreased renal function was approximately 2.5% in the present study, which was higher than that reported in several previous studies.20 Several studies have shown that dietary or lifestyle interventions can improve health-related quality of life and eGFR in patients with CKD.21,22 Public health strategies should consider screening for CKD and its associated risk factors so that intensive intervention can reduce these risk factors. Owing to the aging of the population and rapid changes in lifestyle and cardiometabolic risk factors, the prevalence of CKD and MS has rapidly increased in recent years. We also noted a strong independent association between MS and CKD in Chinese adults. The prevalence of CKD increased with an increase in the number of MS components. These associations were independent of age, sex, BMI, and other potential risk factors for CKD. The results of this study were consistent with the results of several previous studies.23,24 Therefore, screening for CKD in high-risk individuals and populations with MS is a cost-effective way to reduce the mortality from progression to CKD and end-stage renal disease (ESRD).

This study further explored the relationship between sociodemographic factors and the risk of CKD. Multivariate logistic regression analysis showed that age (by decade), female sex, low income, low education level and low SES were associated with an increased risk of CKD. A few epidemiological studies have also found that being female is a risk factor for CKD,19,20 but there are also reports with different opinions. It has also been found that female sex is a risk factor for proteinuria but not for decreased renal function,25 which is consistent with the conclusions of this study. Katherine et al26 found that the prevalence of CKD was similar in young people of different sexes, whereas the prevalence of CKD was significantly higher in women than in men in the middle and old age groups. Therefore, further stratified studies of different age and sex groups and related studies with larger sample sizes are needed to confirm the relationship between sex and CKD. Recent studies have also shown a tight association between socioeconomic status and CKD; low income and poor education are negatively correlated with the incidence, progression, and severity of CKD.27,28 A cross-sectional study in the United States also found that the prevalence of CKD was higher among people with lower levels of education and income, and the gap in the prevalence of CKD by socioeconomic status was largely persistent over 28 years.29 Another study found that compared to Caucasians, low-income blacks may have a stronger association with albuminuria, suggesting that albuminuria can be used as the preferred screening indicator for early CKD in low-income populations.30 In this study, after considering the confounding factors of sex and age, we also found that the prevalence of CKD and MS in people with low income or low education level was higher than that in those with high income or high education level, and socioeconomic status was negatively associated with the prevalence of both CKD and MS. The underlying causes may be related to differences in diet, lifestyle, and ideology among people with different incomes, readily available healthcare access and quality. Moreover, the disparity in health information regarding disease awareness, prevention, and lack of health education may also contribute immensely to a further increase in the prevalence of CKD and MS. In this regard, more focused attention needs to be paid on the vulnerable populations with low SES. Improving their social welfare and health education levels will be effective strategies for the prevention and management of these major public health problems.

This study has certain limitations. First, the cross-sectional study design makes it difficult to draw inferences regarding the causal relationship between metabolic syndrome, SES and CKD. Second, the CKD indicator measurements were not tested repeatedly, which may have resulted in the uncertainty of the persistent occurrence of albuminuria, thus leading to a potential overestimation of the prevalence of CKD, as defined in the KDIGO guidelines.31 Third, this study focused on education and income levels as two critical indicators of SES, other SES variables, eg occupation, were not included in the SES assessment. Also, the stratification of SES was based on a questionnaire, we could not avoid information bias. In addition, although an increase in diabetes-related CKD has been observed in China,32 glomerulonephritis remains an important cause of ESRD, and hematuria should also be included as a type of kidney damage. However, taking many other causes of transient hematuria into consideration and being consistent with the previous nationwide study, subjects with hematuria were not included in the estimated prevalence of CKD,9,33 which may lead to an underestimation of the prevalence of CKD.

In conclusion, there is a strong independent association between metabolic syndrome, socioeconomic status and chronic kidney disease in the adult population of Ningbo, China. Metabolic syndromes including elevated blood pressure, elevated blood glucose, dyslipidemia, and abdominal obesity are independent risk factors for chronic kidney disease. In addition, low socioeconomic status including low education and low income levels were identified as independent risk factors for developing CKD and MS. Prevention and treatment strategies for MS are essential to reduce the occurrence of chronic kidney disease, and socioeconomic factors also need to be considered when developing comprehensive strategies for CKD and MS prevention, in order to reduce the incidence and burden of these major chronic diseases.

Institutional Review Board Statement

The study was approved by the Ethics Committee of The First Affiliated Hospital of Ningbo University (Ethics Approval No: 2021RS010), and was performed in accordance with the Declaration of Helsinki treaty.

Data Sharing Statement

The Data presented in this study are available upon request from the corresponding author.

Informed Consent Statement

Written informed consent was obtained from all participants before commencement of the study.

Acknowledgments

We sincerely appreciate the time and effort of all those who contributed to this study.

Funding

This work was supported by grants from the Zhejiang Natural Science Foundation LY20H050003 and Zhejiang Medical Technology Project 2021KY274.

Disclosure

The authors declare no conflict of interest associated with the paper.

References

1. Murray CJ, Atkinson C, Atkinson C, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608. doi:10.1001/jama.2013.13805

2. Collins AJ, Foley RN, Chavers B, et al. ‘United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1):e1–420.

3. Shlipak MG, Tummalapalli SL, Boulware LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int, 2021,99(1):34–47.

4. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404

5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–359. doi:10.1001/jama.287.3.356

6. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154–2169. doi:10.1161/01.CIR.0000095676.90936.80

7. Couser WG, Remuzzi G, Mendis S, et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–1270. doi:10.1038/ki.2011.368

8. Kidney Disease Prognosis C, Matsushita K, van der Velde M. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081.

9. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6

10. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51(3):373–384. doi:10.1053/j.ajkd.2007.11.009

11. Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transpl. 2009;24(7):2117–2123. doi:10.1093/ndt/gfn767

12. Ningbo Municipal Statistics Bureau, 2022 Basic facts about Ningbo. Availabe from: http://tjj.ningbo.gov.cn. Accessed October 15, 2024

13. National Bureau of Statistics, Resident income and consumption expenditure in 2022, Availabe from: www.stats.gov.cn. Accessed October 15, 2024

14. Levey AS, Stevens La Fau Schmid CH, Schmid Ch Fau ZYL, et al. A new equation to estimate glomerular filtration rate. (1539-3704 (Electronic)).

15. Liu J, Grundy Sm Fau - Wang W, Wang W, et al. Ethnic-specific criteria for the metabolic syndrome: evidence from China. 0149–5992.

16. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC. 1538–3598.

17. Kim HA-O, Kwon SA-O, Joh HA-O, et al. The association between arterial stiffness and socioeconomic status: a cross-sectional study using estimated pulse wave velocity. 2056–5909.

18. Kim JY, Kim Sh Fau Cho YJ, Cho YJ Socioeconomic status in association with metabolic syndrome and coronary heart disease risk.

19. GBDCKD C, Purcell CA, Levey AS. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3

20. Zhuang Z, Tong M, Clarke R, et al. Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the meinian onehealth screening survey. Clin Kidney J. 2022;15(12):2228–2236. doi:10.1093/ckj/sfac176

21. Kelly JT, Palmer SC, Wai SN, et al. Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2017;12(2):272–279. doi:10.2215/CJN.06190616

22. Lew QJ, Jafar TH, Koh HW, et al. Red meat intake and risk of ESRD. J Am Soc Nephrol. 2017;28(1):304–312. doi:10.1681/ASN.2016030248

23. Scurt FG, Ganz MJ, Herzog C, et al. Association of metabolic syndrome and chronic kidney disease. Obes Rev. 2023:e13649. doi:10.1111/obr.13649

24. Pammer LM, Lamina C, Schultheiss UT, et al. Association of the metabolic syndrome with mortality and major adverse cardiac events: a large chronic kidney disease cohort. J Intern Med. 2021;290(6):1219–1232. doi:10.1111/joim.13355

25. Lin B, Shao L, Luo Q, et al. Prevalence of chronic kidney disease and its association with metabolic diseases: a cross-sectional survey in Zhejiang province, Eastern China. BMC Nephrol. 2014;15:36. doi:10.1186/1471-2369-15-36

26. Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–957. doi:10.1038/ki.2015.230

27. Bello AK, Peters J, Fau - Rigby J, et al. Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. 1555–905X.

28. Zeng X, Liu J, Tao S, et al. Associations between socioeconomic status and chronic kidney disease: a meta-analysis. 1470–2738.

29. Vart P, Powe NR, McCulloch CE, et al. National trends in the prevalence of chronic kidney disease among racial/ethnic and socioeconomic status groups, 1988-2016. JAMA Network Open. 2020;3(7):e207932. doi:10.1001/jamanetworkopen.2020.7932

30. Crews DC, McClellan WM, Shoham DA, et al. Low income and albuminuria among regards (reasons for geographic and racial differences in stroke) study participants. Am J Kidney Dis. 2012;60(5):779–786. doi:10.1053/j.ajkd.2012.05.010

31. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–180. doi:10.1016/S0140-6736(11)60178-5

32. Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76(2):258–264. doi:10.1053/j.ajkd.2019.05.032

33. Moreno JA, Martin-Cleary C, Gutierrez E, et al. Haematuria: the forgotten CKD factor? Nephrol Dial Transpl. 2012;27(1):28–34. doi:10.1093/ndt/gfr749

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.